Product Information
LEVOCETIRIZINE 2.5 MG/5 ML SOL is a generic product labeled by Chartwell RX LLC, priced at $0.1659 per ML under NDC 62135091738. Its NADAC has been published 190 times since Feb 15, 2023.
FDA first approved this application on May 15, 2017. Its Orange Book therapeutic-equivalence code is AA.
Strength
.5 mg/mL
Manufacturer
Chartwell RX LLCNDC
62135091738
Classification
Generic
Dosage Form
SOLUTION
Route
ORAL
Effective Date
9/23/2026
Active Ingredients
LEVOCETIRIZINE DIHYDROCHLORIDEApproval Type
Generic (ANDA)
FDA Application
ANDA204599FDA Approved
5/15/2017
TE Code
AA
On Market Since
5/15/2017
Pharmacological Classes
Price Statistics
The NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has been published 190 times since Feb 15, 2023, and over the history we have for it it has declined 8.9%. The table below summarizes its recorded NADAC range and movement.
| Current price | $0.1659 per ML |
|---|---|
| All-time high | $0.2218 (Feb 14, 2024) |
| All-time low | $0.1180 (Nov 20, 2024) |
| 52-week high | $0.1690 |
| 52-week low | $0.1409 |
| Median price | $0.1667 |
| Average price | $0.1714 |
| Largest weekly change | -33.4% (Nov 20, 2024) |
| Weeks tracked | 190 |
| Tracking since | Feb 15, 2023 |
Generic Alternatives
No other NADAC-published product shares this drug's active ingredient and strength in a comparable dosage form. Compare the broader picture on the Levocetirizine Dihydrochloride market page.
Lowest-Cost Alternatives
No alternatives available
Related Drugs
Same classification
Continue researching this drug
Use these direct paths to move from a single NDC into the surrounding market, manufacturer, class, and trend context.
Manufacturer
Chartwell RX LLC manufacturer profile
See the full portfolio, pricing trend, and other products from this labeler.
Drug market
Levocetirizine Dihydrochloride market comparison
Compare this molecule across participating manufacturers and inspect the broader market price spread.
Therapeutic class
Histamine-1 Receptor Antagonist class view
See how this drug behaves alongside other products in the same FDA pharmacologic class.
Trend hub
Latest market trends
Zoom back out to the weekly mover view and compare this NDC with the rest of the current NADAC release.
Guide
Understanding NADAC pricing
Use the explainer when you need context on how CMS publishes NADAC and how to interpret the number on this page.
Frequently asked questions
What is the NADAC price of LEVOCETIRIZINE 2.5 MG/5 ML SOL?
The current National Average Drug Acquisition Cost (NADAC) for LEVOCETIRIZINE 2.5 MG/5 ML SOL, manufactured by Chartwell RX LLC, is $0.1659 per ML (NDC 62135091738), effective Sep 30, 2026.
How has the price of LEVOCETIRIZINE 2.5 MG/5 ML SOL changed over time?
Over the history we have for it, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has declined 8.9%. It has been tracked across 190 weekly CMS publications since Feb 15, 2023.
What are the highest and lowest recorded NADAC prices for LEVOCETIRIZINE 2.5 MG/5 ML SOL?
Since Feb 15, 2023, the NADAC for LEVOCETIRIZINE 2.5 MG/5 ML SOL has ranged from a low of $0.1180 (Nov 20, 2024) to a high of $0.2218 (Feb 14, 2024), with a median of $0.1667 per ML.
Are there cheaper alternatives to LEVOCETIRIZINE 2.5 MG/5 ML SOL?
No other NADAC-published product currently shares the active ingredient and strength of LEVOCETIRIZINE 2.5 MG/5 ML SOL in a comparable dosage form, so no direct lower-cost alternative is listed.
Who manufactures LEVOCETIRIZINE 2.5 MG/5 ML SOL?
LEVOCETIRIZINE 2.5 MG/5 ML SOL (NDC 62135091738) is labeled by Chartwell RX LLC, and CMS classifies it as a generic product.